al102
ayala pharmaceuticalsceuticals,novartis
['al102', 'pivotal', 'ayala', '$ayla']
release ayala pharmaceuticalsceuticals presents positive interim data from ringside pivotal phase 2-3 trial of al102 in desmoid tumors at esmo congress 2022 $ayla #investing #pharmaceuticals #oncology 
A free small & microcap focused investor portal - news, research, videos, market data - The SmallCap Authority